Sangamo showcases progress in our pre-clinical programs at ESGCT.

Click here to view

AD/PD 2021

Zinc Finger Protein Transcription Factor-Mediated Repression of Alpha-Synuclein Expression as a Therapeutic Approach for Parkinson’s Disease
May 28th, 2021